Madrigal Pharmaceuticals
$489.73
50
+$0.42+0.09% Monday 21:00
Statistics
Day High
497.26
Day Low
481.57
52W High
615
52W Low
265
Volume
253,814
Avg. Volume
358,634
Mkt Cap
11.12B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
4MarExpected
Expected EPS
-0.916541
Actual EPS
N/A
Financials
-258.64%Profit Margin
Unprofitable360.27MRevenue
-931.78MNet Income
Analyst Ratings
$629.60Average Price Target
The highest estimate is 900.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy 73%
Hold 27%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MDGL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Viking Therapeutics
VKTX
Mkt Cap4.3B
Gilead Sciences
GILD
Mkt Cap148.78B
Galmed Pharmaceuticals
GLMD
Mkt Cap7.51M
Agios Pharmaceuticals
AGIO
Mkt Cap2.52B
FibroGen
FGEN
Mkt Cap44.97M
Axsome Therapeutics
AXSM
Mkt Cap6.74B
Novartis
NVS
Mkt Cap237.61B
About
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Show more...
CEO
Mr. William J. Sibold
Employees
528
Country
US
ISIN
US5588681057
Listings
0 Comments
Share your thoughts
FAQ
What is Madrigal Pharmaceuticals stock price today?▼
The current price of MDGL is $489.73 USD — it has increased by +0.09% in the past 24 hours. Watch Madrigal Pharmaceuticals stock price performance more closely on the chart.
What is Madrigal Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Madrigal Pharmaceuticals stocks are traded under the ticker MDGL.
Is Madrigal Pharmaceuticals stock price growing?▼
MDGL stock has fallen by -2.13% compared to the previous week, the month change is a -17.54% fall, over the last year Madrigal Pharmaceuticals has showed a +50.47% increase.
What is Madrigal Pharmaceuticals market cap?▼
Today Madrigal Pharmaceuticals has the market capitalization of 11.12B
When is the next Madrigal Pharmaceuticals earnings date?▼
Madrigal Pharmaceuticals is going to release the next earnings report on March 04, 2026.
What were Madrigal Pharmaceuticals earnings last quarter?▼
MDGL earnings for the last quarter are -5.08 USD per share, whereas the estimation was -2.29 USD resulting in a -122.31% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Madrigal Pharmaceuticals revenue for the last year?▼
Madrigal Pharmaceuticals revenue for the last year amounts to 360.27M USD.
What is Madrigal Pharmaceuticals net income for the last year?▼
MDGL net income for the last year is -931.78M USD.
How many employees does Madrigal Pharmaceuticals have?▼
As of February 03, 2026, the company has 528 employees.
In which sector is Madrigal Pharmaceuticals located?▼
Madrigal Pharmaceuticals operates in the Health Care sector.
When did Madrigal Pharmaceuticals complete a stock split?▼
The last stock split for Madrigal Pharmaceuticals was on July 25, 2016 with a ratio of 1:35.
Where is Madrigal Pharmaceuticals headquartered?▼
Madrigal Pharmaceuticals is headquartered in West Conshohocken, US.